C
Caris Life Sciences Inc
NASDAQ:CAI
Caris Life Sciences Inc
NASDAQ:CAI
Price:
19.55
USD
-4.21%
Market Closed
Market Cap:
$5.5B
Income Statement
Earnings Waterfall
Caris Life Sciences Inc
Caris Life Sciences Inc
Income Statement
Caris Life Sciences Inc
Caris Life Sciences Inc
Currency:
| Jun-2025 | Sep-2025 | ||
|---|---|---|---|
| Revenue | |||
| Interest Expense |
32
|
45
|
|
| Revenue |
715
N/A
|
931
+30%
|
|
| Gross Profit | |||
| Cost of Revenue |
(363)
|
(433)
|
|
| Gross Profit |
351
N/A
|
499
+42%
|
|
| Operating Income | |||
| Operating Expenses |
(684)
|
(799)
|
|
| Selling, General & Administrative |
(522)
|
(615)
|
|
| Research & Development |
(162)
|
(184)
|
|
| Operating Income |
(333)
N/A
|
(300)
+10%
|
|
| Pre-Tax Income | |||
| Interest Income Expense |
(104)
|
(113)
|
|
| Non-Reccuring Items |
(18)
|
(18)
|
|
| Total Other Income |
(1)
|
(1)
|
|
| Pre-Tax Income |
(456)
N/A
|
(432)
+5%
|
|
| Net Income | |||
| Tax Provision |
0
|
0
|
|
| Income from Continuing Operations |
(456)
|
(432)
|
|
| Net Income (Common) |
(1 022)
N/A
|
(998)
+2%
|
|
| EPS (Diluted) |
-3.63
N/A
|
-3.35
+8%
|
|
Switch to:
Switch to:
See Also
Discover More
